mupirocin

Poland

Drugs containing this active substance

  • BACTROBAN

    The medicine is used to eliminate staphylococcal bacteria from the nose, including MRSA strains.

    Form: ointment for nasal use

    Active substance Dosage
    mupirocin 20 mg/g

    ATC: D06AX09

    Manufacturer: GlaxoSmithKline, S.A.

  • BACTROBAN

    The medicine is used to eliminate staphylococcal bacteria from the nose, including MRSA strains.

    Form: ointment for nasal use

    Active substance Dosage
    mupirocin 20 mg/g

    ATC: R01AX06

    Manufacturer: Beecham Portuguesa – Pharmaceutical and Chemical Products, Ltd.

  • BACTROBAN

    The ointment is used to eliminate staphylococcal bacteria (including MRSA strains) located in the nose.

    Form: ointment for nasal use

    Active substance Dosage
    mupirocin 20 mg/g

    ATC: R01AX06

    Manufacturer: Stiefel Farma, S.A.

  • BACTROBAN

    The ointment is used to eliminate staphylococcal bacteria (including MRSA strains) located in the nose.

    Form: ointment for nasal use

    Active substance Dosage
    mupirocin 20 mg/g

    ATC: R01AX06

    Manufacturer: GlaxoSmithKline Monoprosopi A.E.B.E.

  • BACTROBAN

    The medicine is used to eliminate staphylococcal bacteria from the nose, including MRSA strains.

    Form: ointment for nasal use

    Active substance Dosage
    mupirocin 20 mg/g

    ATC: D06AX09

    Manufacturer: Laboratoire GlaxoSmithKline

  • BACTROBAN

    The ointment is used to eliminate staphylococcal bacteria (including MRSA strains) located in the nose.

    Form: ointment for nasal use

    Active substance Dosage
    mupirocin 20 mg/g

    ATC: R01AX06

    Manufacturer: GlaxoSmithKline (Ireland) Limited

  • BACTROBAN

    The ointment is used to eliminate staphylococcal bacteria (including MRSA strains) located in the nose.

    Form: ointment for nasal use

    Active substance Dosage
    mupirocin 20 mg/g

    ATC: R01AX06

    Manufacturer: GlaxoSmithKline Monoprosopi A.E.B.E.

  • BACTROBAN

    The medicine is used for the topical treatment of bacterial skin infections (such as impetigo, folliculitis, or furunculosis) and to prevent infections of minor wounds, abrasions, and sutured wounds. It is intended for topical use on the skin only.

    Form: ointment

    Active substance Dosage
    mupirocin 20 mg/g

    ATC: D06AX09

    Manufacturer: GlaxoSmithKline Monoprosopi A.E.B.E.

  • BACTROBAN

    It is used for the topical treatment of bacterial skin infections, such as impetigo, folliculitis, or furunculosis. It also helps to prevent infections in the case of minor wounds, abrasions, and sutured wounds.

    Form: ointment

    Active substance Dosage
    mupirocin 20 mg/g

    ATC: D06AX09

    Manufacturer: GlaxoSmithKline, S.A.

  • BACTROBAN

    The medicine is used to eliminate staphylococcal bacteria (including MRSA strains) located in the nose.

    Form: ointment for nasal use

    Active substance Dosage
    mupirocin 20 mg/g

    ATC: R01AX06

    Manufacturer: Laboratoire GlaxoSmithKline

  • BACTROBAN

    The medicine is used to eliminate staphylococcal bacteria from the nose, including MRSA strains.

    Form: ointment for nasal use

    Active substance Dosage
    mupirocin 20 mg/g

    ATC: R01AX06

    Manufacturer: GlaxoSmithKline (Ireland) Limited

  • BACTROBAN

    The ointment is used to eliminate staphylococcal bacteria from the nose, including MRSA strains.

    Form: ointment for nasal use

    Active substance Dosage
    mupirocin 20 mg/g

    ATC: D06AX09

    Manufacturer: Laboratoire GlaxoSmithKline

  • BACTROBAN

    The ointment is used to eliminate staphylococcal bacteria (including MRSA strains) from the nose.

    Form: ointment for nasal use

    Active substance Dosage
    mupirocin 20 mg/g

    ATC: R01AX06

    Manufacturer: GlaxoSmithKline Pharmaceuticals S.A.

  • BACTROBAN

    The ointment is used to eliminate staphylococcal bacteria (including MRSA strains) located in the nose.

    Form: ointment for nasal use

    Active substance Dosage
    mupirocin 20 mg/g

    ATC: D06AX09

    Manufacturer: GlaxoSmithKline Pharma GmbH

  • BACTROBAN

    The medicine is used to eliminate staphylococci bacteria (including MRSA strains) located in the nose.

    Form: ointment for nasal use

    Active substance Dosage
    mupirocin 20 mg/g

    ATC: D06AX09

    Manufacturer: GlaxoSmithKline Pharmaceuticals S.A.

  • BACTROBAN

    The medicine is used to eliminate staphylococcal bacteria from the nose, including MRSA strains.

    Form: ointment for nasal use

    Active substance Dosage
    mupirocin 20 mg/g

    ATC: R01AX06

    Manufacturer: GlaxoSmithKline Trading Services Limited

  • BACTROBAN

    The ointment is used to eliminate staphylococcal bacteria (including MRSA strains) located in the nose.

    Form: ointment for nasal use

    Active substance Dosage
    mupirocin 20 mg/g

    ATC: R01AX06

    Manufacturer: GlaxoSmithKline Pharma GmbH

  • BACTROBAN

    The ointment is used to eliminate staphylococcal bacteria (including MRSA strains) located in the nose.

    Form: ointment for nasal use

    Active substance Dosage
    mupirocin 20 mg/g

    ATC: R01AX06

    Manufacturer: GlaxoSmithKline, S.A.

  • BACTROBAN

    The ointment is used to eliminate staphylococcal bacteria (including MRSA strains) located in the nose.

    Form: ointment for nasal use

    Active substance Dosage
    mupirocin 20 mg/g

    ATC: R01AX06

    Manufacturer: GlaxoSmithKline Trading Services Limited

  • BACTROBAN

    The medicine is used to eliminate staphylococcal bacteria from the nose, including MRSA strains.

    Form: ointment for nasal use

    Active substance Dosage
    mupirocin 20 mg/g

    ATC: R01AX06

    Manufacturer: GlaxoSmithKline, S.A.

  • MUBACTIN

    The medicine is used to eliminate staphylococcal bacteria from the nose, including MRSA strains.

    Form: ointment for nasal use

    Active substance Dosage
    mupirocin 20 mg/g

    ATC: R01AX06

    Manufacturer: Mako Pharma Sp. z o.o.

  • MUPINA

    This is an antibiotic nasal ointment used to fight staphylococcal bacteria (including the MRSA strain) located in the nose.

    Form: ointment for nasal use

    Active substance Dosage
    mupirocin 20 mg/g

    ATC: R01AX06

    Manufacturer: Infectopharm Arzneimittel und Consilium GmbH

  • MUPIROX

    The medicine is used topically for the treatment of bacterial skin infections, such as impetigo, folliculitis, boils, and secondary skin infections.

    Form: ointment

    Active substance Dosage
    mupirocin 20 mg/1 g

    ATC: D06AX09

    Manufacturer: EMO-FARM Sp. z o.o.

  • SOLTOPIN

    It is used in the treatment of skin infections, such as folliculitis (with pustules), impetigo (a disease with blisters and crusts), and recurrent furunculosis. It acts against bacteria, including strains of Staphylococcus, Streptococcus, and Escherichia coli.

    Form: ointment

    Active substance Dosage
    mupirocin 2.2 g/100 g

    ATC: D06AX09

    Manufacturer: Infectopharm Arzneimittel und Consilium GmbH

  • TACONAL

    It is used for the topical treatment of bacterial skin infections, such as impetigo, folliculitis, or furunculosis.

    Form: ointment

    Active substance Dosage
    mupirocin 20 mg/g

    ATC: D06AX09

    Manufacturer: Aflofarm Farmacja Polska Limited